129 related articles for article (PubMed ID: 38278557)
1. Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition.
Qu J; Xue X; Wang Z; Ma Z; Jia K; Li F; Zhang Y; Wu R; Zhou F; Zhao P; Li X
Chin J Nat Med; 2024 Jan; 22(1):31-46. PubMed ID: 38278557
[TBL] [Abstract][Full Text] [Related]
2. Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment.
Ma Z; Xue X; Bai J; Cai Y; Jin X; Jia K; Ding M; Lyu X; Li X
Biomed Pharmacother; 2022 Nov; 155():113834. PubMed ID: 36271584
[TBL] [Abstract][Full Text] [Related]
3. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
4. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
[TBL] [Abstract][Full Text] [Related]
5. Danhongqing formula alleviates cholestatic liver fibrosis by downregulating long non-coding RNA H19 derived from cholangiocytes and inhibiting hepatic stellate cell activation.
Li M; Zhou Y; Zhu H; Xu LM; Ping J
J Integr Med; 2024 Mar; 22(2):188-198. PubMed ID: 38472011
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
[TBL] [Abstract][Full Text] [Related]
7. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
[TBL] [Abstract][Full Text] [Related]
8. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
[TBL] [Abstract][Full Text] [Related]
9. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis.
Xue X; Wu J; Ding M; Gao F; Zhou F; Xu B; Lu M; Li J; Li X
Chin Med; 2021 Nov; 16(1):112. PubMed ID: 34736501
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells.
Wang Z; Yang X; Kai J; Wang F; Wang Z; Shao J; Tan S; Chen A; Zhang F; Wang S; Zhang Z; Zheng S
Life Sci; 2020 Aug; 255():117818. PubMed ID: 32445757
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal.
Xia S; Wang Z; Chen L; Zhou Y; Li Y; Wang S; Chen A; Xu X; Shao J; Zhang Z; Tan S; Zhang F; Zheng S
Biochem Pharmacol; 2021 Oct; 192():114730. PubMed ID: 34400125
[TBL] [Abstract][Full Text] [Related]
12. Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA.
Ma Z; Xie K; Xue X; Li J; Yang Y; Wu J; Li Y; Li X
J Ethnopharmacol; 2024 Jun; 328():118057. PubMed ID: 38518965
[TBL] [Abstract][Full Text] [Related]
13. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
[TBL] [Abstract][Full Text] [Related]
14. DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis.
Yang JJ; She Q; Yang Y; Tao H; Li J
Toxicol Lett; 2018 Oct; 295():325-334. PubMed ID: 30010033
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
Sun J; Zhang H; Li L; Yu L; Fu L
Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
Chilvery S; Bansod S; Saifi MA; Godugu C
Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
[TBL] [Abstract][Full Text] [Related]
19. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
20. miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.
Qiu J; Wu S; Wang P; Zhou Y; Wang Z; Sun Y; Jiang C
Hepatol Int; 2023 Apr; 17(2):463-475. PubMed ID: 36001230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
